We are pleased to announce that registration is now open for the second of a three-part webinar series on desensitisation taking place on Thursday, 7 April 2022 at 18:00 – 19:00 CEST! Moderated by Lucrezia Furian and with Frans Claas and Nizam Mamode as speakers, the webinar HLA antibodies, crossmatching and outcomes after HLA incompatible
Registration now open for the webinar 𝘿𝙚𝙨𝙚𝙣𝙨𝙞𝙩𝙞𝙨𝙖𝙩𝙞𝙤𝙣 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙚𝙨 on 𝗧𝘂𝗲𝘀𝗱𝗮𝘆, 𝟭 𝗠𝗮𝗿𝗰𝗵 𝗮𝘁 𝟭𝟴:𝟬𝟬 𝗖𝗘𝗧!
With Prof. Nizam Mamode & Prof. Christophe Legendre
This activity is sponsored by Hansa Biopharma
3-years Postdoctoral position in Transplant Immunology at the Vall d’Hebron Institute of Research (VHIR), in the Translational Nephrology and Transplantation Laboratory group leaded by professor Oriol Bestard, in Barcelona. Learn more: VHIR-PostDoc position_Dr OriolBestard How to apply: Applicants should submit a full Curriculum Vitae and a cover letter with the reference “post-doctoral position at the
This educational webinar will discuss the efficacy of current COVID-19 vaccine strategies for transplanted patients. The first talk will focus on the experience with heterologous vaccinations and the pro´s and con´s for vector vaccines in transplant patients. The second talk summarises previous studies on second and third booster (homogenous and heterologous) vaccinations – and gives
Recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies We are pleased to present the recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies. Over recent months, our group
We would like to announce a call for nominations for four new Board members. All ESOT/EKITA affiliates are welcome to send nominations for this position. You may nominate yourself or a colleague. The new EKITA Board members will hold office for 4 years (2021-2025), effective from the ESOT Congress in Milan. The EKITA Board is
On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of additional European national authorities and expect to finalise agreement with participating countries by the end of April 2021. In addition, ESOT is establishing contacts with non-European countries and registries. read more
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.